Stock listing

A2QGM4 Stock Price, News, Filings & Events — Remegen Co. Ltd. Class A

Selected listing: A2QGM4 · LS · EUR · DE

A2QGM4:LS is the listing for Remegen Co. Ltd. Class A, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The company is actively engaged in clinical trials and research to advance its product pipeline. Recent news includes updates on trial results and regulatory filings that may impact its market position. Investors can find relevant events and announcements that provide insights into the company's strategic direction and performance in the biopharmaceutical sector.

A2QGM4:LSEURDEUpdated July 21, 2026
Remegen Co. Ltd. Class A logo
Ticker
A2QGM4:LS
Asset type
Stock
Market cap
$9.44B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS
Currency
EUR

Remegen Co. Ltd. Class A A2QGM4:LS stock context

A2QGM4:LS is the listing for Remegen Co. Ltd. Class A, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. The company is actively engaged in clinical trials and research to advance its product pipeline. Recent news includes updates on trial results and regulatory filings that may impact its market position. Investors can find relevant events and announcements that provide insights into the company's strategic direction and performance in the biopharmaceutical sector.

Research Remegen Co. Ltd. Class A

Alternate listings